Phanstiel S. Louise bought MYGN
February 25, 2026 · Form 4 insider transaction
Phanstiel S. Louise bought 6,100 shares of Myriad Genetics, Inc. at $4.74 per share, a transaction worth $28.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,100
Price
$4.74
Total value
$28.9K
InsiderPhanstiel S. Louise
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 25, 2026
Filing dateFebruary 27, 2026
Shares owned after183,544
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.725 to $4.75, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.